Table 1

Comparison of patients with an ICH to the case controls

ICH cases, n = 40 (%)Case controls, n = 80 (%)
Sex   
    Female 22 (55) 35 (44) 
    Male 18 (45) 45 (56) 
ITP duration   
    Acute ITP less than 6 mo 28 (70) 66 (82.5) 
    Chronic ITP 6 mo or more 12 (30) 14 (17.5) 
Platelet counts   
    Median, platelets/μL 5000 8000 
    Range, platelets/μL 1 to 61 000 1 to 28 000 
    Platelet count less than 20 000/μL 36 (90) 68 (85) 
    Platelet count less than 10 000/μL 30 (75) 47 (59) 
Age   
    Age range 3 mo-17 y 2 mo-17 y 
    Number of patients younger than 10 y old 23 (58) 53 (66) 
    Number of patients 10 y or older 17 (43) 27 (34) 
NSAID use*   
    Number of patients reporting recent NSAID use 3 (7.5) 1 (1.25) 
Head trauma* 13 (33) 1 (1) 
Bleeding symptoms*   
    No bleeding 3 (7.5) 4 (5) 
    Any bleeding 37 (92.5) 76 (95) 
    Petechiae 25 (63) 64 (80) 
    Ecchymosis 30 (75) 60 (75) 
    Bleeding other than petechiae and ecchymosis 25 (63) 35 (44) 
    Wet purpura 11 (27.5) 15 (19) 
    Epistaxis 15 (37.5) 19 (24) 
    Gum bleeding 9 (22.5) 8 (10) 
    GI bleeding 7 (17.5) 5 (6) 
    U bleeding 9 (22.5) 0 (0) 
    GYN bleeding 3 (4) 
Head trauma and bleeding symptoms   
    Both head trauma and bleeding other than petechiae and ecchymosis 4 (10) 0 (0) 
    Head trauma and no bleeding other than petechiae and ecchymosis 9 (23) 1 (1) 
    No head trauma but bleeding other than petechiae and ecchymosis 20 (51) 35 (44) 
    No head trauma and no bleeding other than petechiae and ecchymosis 6 (15) 44 (55) 
ICH cases, n = 40 (%)Case controls, n = 80 (%)
Sex   
    Female 22 (55) 35 (44) 
    Male 18 (45) 45 (56) 
ITP duration   
    Acute ITP less than 6 mo 28 (70) 66 (82.5) 
    Chronic ITP 6 mo or more 12 (30) 14 (17.5) 
Platelet counts   
    Median, platelets/μL 5000 8000 
    Range, platelets/μL 1 to 61 000 1 to 28 000 
    Platelet count less than 20 000/μL 36 (90) 68 (85) 
    Platelet count less than 10 000/μL 30 (75) 47 (59) 
Age   
    Age range 3 mo-17 y 2 mo-17 y 
    Number of patients younger than 10 y old 23 (58) 53 (66) 
    Number of patients 10 y or older 17 (43) 27 (34) 
NSAID use*   
    Number of patients reporting recent NSAID use 3 (7.5) 1 (1.25) 
Head trauma* 13 (33) 1 (1) 
Bleeding symptoms*   
    No bleeding 3 (7.5) 4 (5) 
    Any bleeding 37 (92.5) 76 (95) 
    Petechiae 25 (63) 64 (80) 
    Ecchymosis 30 (75) 60 (75) 
    Bleeding other than petechiae and ecchymosis 25 (63) 35 (44) 
    Wet purpura 11 (27.5) 15 (19) 
    Epistaxis 15 (37.5) 19 (24) 
    Gum bleeding 9 (22.5) 8 (10) 
    GI bleeding 7 (17.5) 5 (6) 
    U bleeding 9 (22.5) 0 (0) 
    GYN bleeding 3 (4) 
Head trauma and bleeding symptoms   
    Both head trauma and bleeding other than petechiae and ecchymosis 4 (10) 0 (0) 
    Head trauma and no bleeding other than petechiae and ecchymosis 9 (23) 1 (1) 
    No head trauma but bleeding other than petechiae and ecchymosis 20 (51) 35 (44) 
    No head trauma and no bleeding other than petechiae and ecchymosis 6 (15) 44 (55) 

GI indicates gastrointestinal; U, urinary; and GYN, gynecological/vaginal.

*

Data for bleeding symptoms, NSAID use, and head trauma were considered negative if no specific response was provided on the questionnaire.

Close Modal

or Create an Account

Close Modal
Close Modal